Significant Shortfalls in Ocular Drug Delivery Technology Anticipated in COVID-19 Crisis
It is anticipated that glaucoma cases will surpass 100 million by 2040, while macular degeneration shall reach nearly 200 million by 2020-end. These increasing cases are poised to heighten prospects for ocular drug delivery market in the forecast period (2020-2025). Immense research and development are occurring